Insider Trading activities at Unicycive Therapeutics, Inc. (UNCY)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Unicycive Therapeutics, Inc. (UNCY) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Unicycive Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1766140.

Total stock buying since 2022: $12,375.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.


4 insiders reported insider trading activities at Unicycive Therapeutics, Inc. (UNCY):
Insider trading activities of Jermasek Douglas
Insider trading activities of Schiller Brigitte
Insider trading activities of Gupta Pramod
Insider trading activities of Gupta Shalabh K.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Unicycive Therapeutics, Inc. (UNCY).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 0 $0 0 $0 251,069 $0
2022 15,000 $12,375 0 $0 0 $0

Table 2. Monthly summary of insider trading at Unicycive Therapeutics, Inc. (UNCY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-07 0 $0 0 $0 251,069 $0
2022-05 15,000 $12,375 0 $0 0 $0

Table 3. Detailed insider trading at Unicycive Therapeutics, Inc. (UNCY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-07-11 Jermasek Douglas (EVP of Corporate Strategy) Option Ex 104,612 .00 0
2023-07-11 Gupta Shalabh K. (CEO) Option Ex 104,612 .00 0
2023-07-11 Gupta Pramod (EVP, Pharmaceuticals and BD) Option Ex 41,845 .00 0
2022-05-16 Schiller Brigitte Buy 15,000 .82 12,375

Insider trading activities including stock purchases, stock sales, and option exercises of UNCY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Unicycive Therapeutics, Inc. (symbol UNCY, CIK number 1766140) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.